{"database": "lobbying", "table": "lobbying_activities", "rows": [[2470411, "cf5b2a53-dc52-4c1b-9105-538c7f7841bc", "Q2", "HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)", 28776, "HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)", 2020, "second_quarter", "PHA", "Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271)\nIssues related to ARCOS data and suspicious order record requirements and reporting \nImportation of Prescription Drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844, Public Law 108-173) \nImplementation of Public Law 113-54 (DSCSA) \nBlock, Report, And Suspend Suspicious Shipments Act of 2019 (HR 3878)", "Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 334536, 0, 0, "2020-07-17T08:55:45.857000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2470411"], "units": {}, "query_ms": 47.003973042592406, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}